Sign In
Buy ALRN
$2.11
+0 (+0%)
At Close: Apr 09, 2025
BOSTON, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patie
Aileron Therapeutics to Present at Upcoming H.C. Wainwright Virtual Global Investment Conference
04:05pm, Tuesday, 07'th Sep 2021
BOSTON, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patie
BOSTON, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patien
Aileron Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
04:20pm, Wednesday, 11'th Aug 2021
-- --
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
08:15am, Thursday, 08'th Jul 2021
BOSTON, July 08, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patient
Aileron Launches Early-Stage Study For Chemoprotective Candidate In Lung Cancer Settings
01:39pm, Thursday, 01'st Jul 2021
Aileron Therapeutics Inc (NASDAQ: ALRN) has initiated Phase 1b trial of ALRN-6924 as a chemoprotective agent to treat patients with non-small cell lung cancer undergoing chemotherapy. Aileron pla
Aileron Therapeutics to be Added to the Russell Microcap® Index
07:00am, Thursday, 24'th Jun 2021
BOSTON, June 24, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patient
-- Fireside chat, moderated by Soumit Roy, Ph.D. of JonesTrading, will be held on Wednesday, May 26, 2021 at 11:00 am ET -- -- Featured speakers will include hematologist Alan List, M.D. and geri
Aileron Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
04:18pm, Tuesday, 11'th May 2021
-- --
Aileron Therapeutics: Solving Chemotherapy's Toxicity
09:54pm, Friday, 30'th Apr 2021
Chemotherapy is built into the treatment regime of nearly every cancer. However, chemotherapy's well-known toxicity can lead to patient discontinuation and poor quality-of-life.
Aileron Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
04:36pm, Wednesday, 24'th Mar 2021
-- --
Aileron Therapeutics: Low Cash Balance, Early Stage, But Scientific Premise Is Interesting
03:46am, Wednesday, 10'th Feb 2021
Aileron Therapeutics has a long history of not doing much. Its data is early stage, but the scientific theory is interesting.
7 Penny Stocks That Actually Have Buy Ratings
01:22pm, Wednesday, 03'rd Feb 2021
Many penny stocks are destined to fail, but these seven penny stocks may succeed. Wall Street has buy recommedations on them.
-- Several existing Aileron investors, including Satter Medical Technology Partners and Lincoln Park Capital Fund, LLC, also participated in the offering -- – Aileron plans to use net proceeds to
Aileron Therapeutics Announces $35.9 Million Registered Direct Offering
09:30am, Wednesday, 06'th Jan 2021
WATERTOWN, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (Nasdaq: ALRN), today announced that it has entered into definitive agreements with fundamental healthcare investors for
